Symeres Acquires Exemplify BioPharma
October 25, 2022
Symeres, a Netherlands-headquartered transatlantic CRO/CDMO majority‑owned by Keensight Capital, has acquired Exemplify BioPharma, a Cranbury, New Jersey-based CMC-focused CRO. The deal strengthens Symeres' capabilities in process and analytical chemistry and formulation development and further expands its strategic foothold in the United States.
- Buyers
- Symeres, Keensight Capital
- Targets
- Exemplify BioPharma
- Platforms
- Symeres
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.